Abstract
JC virus (JCV) is a human polyomavirus that causes progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease that mainly affects immunocompromised subjects. Since its discovery, PML has been considered a rapidly progressing fatal disease; however, amino acid substitutions in the capsid viral protein have recently been tentatively associated with changes in PML clinical course. In order to provide more insight to PML pathogenesis and identify potential prognostic markers, seven cerebrospinal fluid (CSF) samples and four brain autopsy samples were collected from patients afflicted with PML with different clinical courses (fast- and slow-progressing), and the JCV VP1 coding region was amplified, cloned, and sequenced. In addition, urine samples were collected and analyzed from nine patients with PML or other neurological diseases (ONDs) as a control group. Sequencing analysis of the genomic region encoding the VP1 outer loops revealed polymorphic residues restricted to four positions (74, 75, 117, and 128) in patients with slow PML progression, whereas no significant mutation was found in JCV isolated from urine. Collectively, these data show that JCV VP1 loop mutations are associated with a favorable prognosis for PML. It is therefore possible that slower progression of PML may be related to the emergence of a less virulent JCV strain with a lower replication rate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, Eggers C, Stellbrink HJ (1998). Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12: 1149–1154.
Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, Grisetti S, Moretti F, Vigo B, Bongiovanni M, Del Grosso B, Arcidiacono MI, Fibbia GC, Mena M, Finazzi MG, Guaraldi G, Ammassari A, d’Arminio Monforte A, Cinque P, De Luca A; Italian Registry Investigative Neuro AIDS Study Group (2003). Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J NeuroVirol 9(Suppl 1): 47–53.
Ault GS, Stoner GL (1993). Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. J Gen Virol 74: 1499–1507.
Berger JR, Pall L, Lanska D, Whiteman M (1998). Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4: 59–68.
Berger JR, Kaszovitz B, Donovan Post MJ, Dickinson G (1987). Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann Intern Med 107: 78–87.
Brooks BR, Walker DL (1984). Progressive multifocal leukoencephalopathy. Neurol Clin 2: 299–313.
Chang D, Liou ZM, Ou WC, Wang KZ, Wang M, Fung CY, Tsai RT (1996). Production of the antigen and the antibody of the JC virus major capsid protein VP1. J Virol Methods 59: 177–187.
Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD (2003). Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 31: 3497–3500.
Cinque P, Casari S, Bertelli D (1998). Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy. N Engl J Med 339: 848–849.
Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52: 623–625.
Delbue S, Pagani E, Guerini FR, Agliardi C, Mancuso R, Borghi E, Rossi F, Boldorini R, Veggiani C, Car PG, Ferrante P (2005). Distribution, characterization and significance of polyomavirus genomic sequences in tumors of the brain and its covering. J Med Virol 77: 447–454.
Delbue S, Sotgiu G, Fumagalli D, Valli M, Borghi E, Mancuso R, Marchioni E, Maserati R, Ferrante P (2005). A case of a PML patient with four different JC virus TCR rearrangements in CSF, blood, serum and urine. J NeuroVirol 11: 51–57.
Dugan A, Gasparovic ML, Tsomaia N, Mierke DF, O’Hara B, Manley K, Atwood WJ (2007). Identification of amino acid residues in BK virus VP1 critical for viability and growth. J Virol 81: 11798–11808.
Eckert KA, Kunkel TA (1990). High fidelity DNA synthesis by the Thermus aquaticus DNA polymerase. Nucleic Acids Res 18: 3739–3744.
Frisque RJ, Bream GL, Cannella MT (1984). Human polyomavirus JC virus genome. J Virol 51: 458–469.
Gee GV, Tsomaia N, Mierke DF, Atwood WJ (2004). Modeling a sialic acid binding pocket in the external loops of JC virus VP1. J Biol Chem 279: 49172–49176.
Liddington RC, Yan Y, Moulai J, Sahli R, Benjamin TL, Harrison SC (1991). Structure of simian virus 40 at 3.8-A resolution. Nature 354: 278–284.
Loeber G, Dories K (1998). DNA rearrangements in organ-specific variants of polyomavirus JC strain GS. J Virol 62: 1730–1735.
Stehle T, Gamblin SJ, Yan Y, Harrison SC (1996). The structure of simian virus 40 refined at 3.1 A resolution. Structure 4: 165–182.
Walker DL, Padgett BL (1983). The epidemiology of human polyomaviruses. In: Polyomaviruses and human neurological disease. Sever JL, Madden D (eds). New York: Alan R. Liss, pp 99–106.
Yogo Y, Kitamura T, Sugimoto C, Ueki T, Aso Y, Hara K, Taguchi F (1990). Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol 64: 3139–3143.
Zheng HY, Takasaka T, Noda K, Kanazawa A, Mori H, Kabuki T, Joh K, Oh-ishi T, Ikegaya H, Nagashima K, Hall WW, Kitamura T, Yogo Y (2005a). New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy. J Gen Virol 86: 2035–2045.
Zheng HY, Ikegaya H, Takasaka T, Matsushima-Ohno T, Sakurai M, Kanazawa I, Kishida S, Nagashima K, Kitamura T, Yogo Y (2005b). Characterization of the VP1 loop mutations widespread among JC polyomavirus isolates associated with progressive multifocal leukoencephalopathy. Biochem Biophys Res Commun 333: 996–1002.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by NIH grant no. MH072528 and by a grant from the Italian Minister of Health (ISS 2006) to PF.
Rights and permissions
About this article
Cite this article
Delbue, S., Branchetti, E., Bertolacci, S. et al. JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy. Journal of NeuroVirology 15 (Suppl 1), 51–56 (2009). https://doi.org/10.1080/13550280802425467
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280802425467